Conmed CNMD
NYSE CNMD
$51.37 +0.12 (+0.23%)
As of: Aug 20, 2026 · 3:59 PM EDT

Conmed (CNMD) Return on Invested Capital Growth (3y) (2014 - 2026)

Conmed (CNMD) Return on Invested Capital Growth (3y) (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC Growth (3y) (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn 0.00
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 0.00
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 1.00
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 0.00
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn -
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn -85.00
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 0.00
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 2.00
10 Conmed 1.54 Bn 1.50 Bn 197.46 Mn 0.00

Historic Data

Download Data
DateValue
Jun 30, 2026 0.00
Mar 31, 2026 25.00
Dec 31, 2025 22.00
Sep 30, 2025 21.00
Jun 30, 2025 39.00
Mar 31, 2025 50.00
Dec 31, 2024 56.00
Sep 30, 2024 3.00
Jun 30, 2024 0.00
Mar 31, 2024 2.00
Dec 31, 2023 0.00
Sep 30, 2023 1.00
Jun 30, 2023 1.00
Mar 31, 2023 -1.00
Dec 31, 2022 0.00
Sep 30, 2022 8.00
Jun 30, 2022 8.00
Mar 31, 2022 1.00
Dec 31, 2021 0.00
Sep 30, 2021 0.00